Abstracts and bio's

Elicitation of stakeholder preferences to estimate adherence and adoption of personalized drug treatment.

Personalized medicine is designed to meet the unique needs of a patient as defined by the personal characteristics of his or her disease in order to maximize treatment benefits or minimize treatment risks. However, effectively implementing personalized medicine in the real world may also require a better understanding of the multiple stakeholders who may be involved in the treatment process, including regulators, payers, healthcare providers, caregivers, and patients.  This presentation will discuss the role of stakeholder preferences in personalized medicine and present a framework for understanding how the preferences of different stakeholders may affect uptake, adherence, and real-world treatment outcomes.